Form D · Other Health Care
Averna Therapeutics Inc.
Watertown, MA · CIK 0002020048
Offering snapshot reported Mar 20, 2026 · SEC filing
- Reported sold
- $85M Offering amount: $85M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 8, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$43,769,227 → $84,999,995
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 20, 2026 | Amendment | $84,999,995 | $41,230,768vs Apr 21, 2025 | 13 | SEC filing |
| Apr 21, 2025 | Amendment | $43,769,227 | $5,000,000vs Apr 17, 2024 | 13 | SEC filing |
| Apr 17, 2024 | Initial | $38,769,227 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-510828
Total sales includes dollar value of converted SAFEs.
Series A Convertible Preferred Stock, including underlying common shares ("Convertible Security Shares")
Source: Form D, filed Mar 20, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Roy Amariglio | Director |
| Thomas Barnes | Director, Executive |
| Thomas Barnes, Ph.D. | Director, Executive |
| Henry Chen | Director |
| Alex Harding | Director |
| Richard Morris | Executive |
| Dylan Morris | Director |
| Aaron Nelson | Director |
| Anat Nursella | Executive |
| Nick Olsen | Director |
| Raju Prasad | Director |
| Raju Prasad, Ph.D. | Director |
| Michal Silverberg | Director |
| Stephen Squinto | Director |
| Tal Zaks | Director, Executive |
| Tal Zaks, M.D., Ph.D. | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
134 Coolidge Avenue
Watertown, MA, 10022
Watertown, MA, 10022